Researchers track evolution of HIV antibody

Researchers at the Duke University School of Medicine tracked the evolution of a broadly neutralizing antibody that recognizes different HIV strains, which could lead to the design of a vaccine. Broadly neutralizing antibodies are typically produced after the patient's HIV population has diversified, researchers reported online in Nature.

View Full Article in:

Nature (free content) · New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC